Pneumococcal vaccine (English Wikipedia)

"COVID-19 en vaccinatie tegen pneumokokken (2)" [COVID-19 and vaccination against pneumococcal (2)]. Health Council of the Netherlands (Gezondheidsraad) (in Dutch). 17 December 2020. Archived from the original on 19 September 2021. Retrieved 19 August 2021.

gsk.com

"Synflorix, GlaxoSmithKline's pneumococcal vaccine receives European authorisation" (Press release). GlaxoSmithKline. 31 March 2009. Archived from the original on 4 August 2009.

handle.net

hdl.handle.net

World Health Organization (April 2012). "Pneumococcal vaccines WHO position paper--2012". Weekly Epidemiological Record. 87 (14): 129–144. hdl:10665/241904. PMID 24340399.
World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.

harvard.edu

ui.adsabs.harvard.edu

Jones CH, Zhang G, Nayerhoda R, Beitelshees M, Hill A, Rostami P, et al. (October 2017). "Comprehensive vaccine design for commensal disease progression". Science Advances. 3 (10): e1701797. Bibcode:2017SciA....3E1797J. doi:10.1126/sciadv.1701797. PMC 5647123. PMID 29057325.; Lay summary in: "The end of pneumonia? New vaccine offers hope: Vaccine under development provides the 'most comprehensive coverage' to date and alleviates antimicrobial concerns, new study finds". ScienceDaily. 20 October 2017. Archived from the original on 8 August 2022. Retrieved 12 July 2018.

kb.nl

resolver.kb.nl

"Prik tegen pneumokokken; Alle baby's vanaf april volgend jaar tegen bacterie ingeënt" [Jab against pneumacoccal; All babies vaccinated against bacteria from April of next year]. Algemeen Dagblad (in Dutch). 3 December 2005. Retrieved 4 September 2021 – via Delpher.

laatjevaccineren.be

"Gratis pneumokokkenvaccin voor bewoners van woonzorgcentra" [Free pneumococcal vaccination for the residents of care homes]. laatjevaccineren.be (in Dutch). 9 November 2020. Archived from the original on 28 October 2021. Retrieved 5 September 2021.

medischcontact.nl

van Twillert M (17 December 2020). "Gezondheidsraad: 'Doorgaan met pneumokokkenvaccinatie van ouderen'" [Health council: 'continue pneumococcal vaccination of elderly']. Medisch Contact (in Dutch). Archived from the original on 15 May 2021. Retrieved 4 September 2021.

meningitis.org

"Changes to the immunisation programme in the UK". Meningitis Research Foundation. Archived from the original on 13 July 2007. Retrieved 6 May 2017.

nicd.ac.za

"Critical decline in pneumococcal disease and antibiotic resistance in South Africa". NICD. Archived from the original on 23 July 2015. Retrieved 20 July 2015.

nih.gov

pubmed.ncbi.nlm.nih.gov

World Health Organization (April 2012). "Pneumococcal vaccines WHO position paper--2012". Weekly Epidemiological Record. 87 (14): 129–144. hdl:10665/241904. PMID 24340399.
Grabenstein JD, Klugman KP (October 2012). "A century of pneumococcal vaccination research in humans". Clinical Microbiology and Infection. 18 (Suppl 5): 15–24. doi:10.1111/j.1469-0691.2012.03943.x. PMID 22882735. S2CID 25558809.
Malhame M, Baker E, Gandhi G, Jones A, Kalpaxis P, Iqbal R, et al. (August 2019). "Shaping markets to benefit global health - A 15-year history and lessons learned from the pentavalent vaccine market". Vaccine. 2: 100033. doi:10.1016/j.jvacx.2019.100033. PMC 6668221. PMID 31384748.
von Gottberg A, de Gouveia L, Tempia S, Quan V, Meiring S, von Mollendorf C, et al. (November 2014). "Effects of vaccination on invasive pneumococcal disease in South Africa". The New England Journal of Medicine. 371 (20): 1889–1899. doi:10.1056/NEJMoa1401914. PMID 25386897.
Pletz MW, Maus U, Krug N, Welte T, Lode H (September 2008). "Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species". International Journal of Antimicrobial Agents. 32 (3): 199–206. doi:10.1016/j.ijantimicag.2008.01.021. PMID 18378430. S2CID 10514479.
Stein KE (June 1992). "Thymus-independent and thymus-dependent responses to polysaccharide antigens". The Journal of Infectious Diseases. 165 (Suppl 1): S49–S52. doi:10.1093/infdis/165-supplement_1-s49. PMID 1588177.
Sniadack DH, Schwartz B, Lipman H, Bogaerts J, Butler JC, Dagan R, et al. (June 1995). "Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children--implications for vaccine strategies" (PDF). The Pediatric Infectious Disease Journal. 14 (6): 503–510. doi:10.1097/00006454-199506000-00007. PMID 7667055. Archived from the original on 28 August 2021.
Hanniffy SB, Carter AT, Hitchin E, Wells JM (January 2007). "Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection". The Journal of Infectious Diseases. 195 (2): 185–193. doi:10.1086/509807. PMID 17191163.
Malley R, Lipsitch M, Stack A, Saladino R, Fleisher G, Pelton S, et al. (August 2001). "Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci". Infection and Immunity. 69 (8): 4870–4873. doi:10.1128/IAI.69.8.4870-4873.2001. PMC 98576. PMID 11447162.
Burns T, Abadi M, Pirofski LA (August 2005). "Modulation of the lung inflammatory response to serotype 8 pneumococcal infection by a human immunoglobulin m monoclonal antibody to serotype 8 capsular polysaccharide". Infection and Immunity. 73 (8): 4530–4538. doi:10.1128/IAI.73.8.4530-4538.2005. PMC 1201218. PMID 16040964.
Fabrizio K, Groner A, Boes M, Pirofski LA (April 2007). "A human monoclonal immunoglobulin M reduces bacteremia and inflammation in a mouse model of systemic pneumococcal infection". Clinical and Vaccine Immunology. 14 (4): 382–390. doi:10.1128/CVI.00374-06. PMC 1865609. PMID 17301214.
Jones CH, Zhang G, Nayerhoda R, Beitelshees M, Hill A, Rostami P, et al. (October 2017). "Comprehensive vaccine design for commensal disease progression". Science Advances. 3 (10): e1701797. Bibcode:2017SciA....3E1797J. doi:10.1126/sciadv.1701797. PMC 5647123. PMID 29057325.; Lay summary in: "The end of pneumonia? New vaccine offers hope: Vaccine under development provides the 'most comprehensive coverage' to date and alleviates antimicrobial concerns, new study finds". ScienceDaily. 20 October 2017. Archived from the original on 8 August 2022. Retrieved 12 July 2018.

ncbi.nlm.nih.gov

Malhame M, Baker E, Gandhi G, Jones A, Kalpaxis P, Iqbal R, et al. (August 2019). "Shaping markets to benefit global health - A 15-year history and lessons learned from the pentavalent vaccine market". Vaccine. 2: 100033. doi:10.1016/j.jvacx.2019.100033. PMC 6668221. PMID 31384748.
Malley R, Lipsitch M, Stack A, Saladino R, Fleisher G, Pelton S, et al. (August 2001). "Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci". Infection and Immunity. 69 (8): 4870–4873. doi:10.1128/IAI.69.8.4870-4873.2001. PMC 98576. PMID 11447162.
Burns T, Abadi M, Pirofski LA (August 2005). "Modulation of the lung inflammatory response to serotype 8 pneumococcal infection by a human immunoglobulin m monoclonal antibody to serotype 8 capsular polysaccharide". Infection and Immunity. 73 (8): 4530–4538. doi:10.1128/IAI.73.8.4530-4538.2005. PMC 1201218. PMID 16040964.
Fabrizio K, Groner A, Boes M, Pirofski LA (April 2007). "A human monoclonal immunoglobulin M reduces bacteremia and inflammation in a mouse model of systemic pneumococcal infection". Clinical and Vaccine Immunology. 14 (4): 382–390. doi:10.1128/CVI.00374-06. PMC 1865609. PMID 17301214.
Jones CH, Zhang G, Nayerhoda R, Beitelshees M, Hill A, Rostami P, et al. (October 2017). "Comprehensive vaccine design for commensal disease progression". Science Advances. 3 (10): e1701797. Bibcode:2017SciA....3E1797J. doi:10.1126/sciadv.1701797. PMC 5647123. PMID 29057325.; Lay summary in: "The end of pneumonia? New vaccine offers hope: Vaccine under development provides the 'most comprehensive coverage' to date and alleviates antimicrobial concerns, new study finds". ScienceDaily. 20 October 2017. Archived from the original on 8 August 2022. Retrieved 12 July 2018.

nytimes.com

Wilson D (24 February 2010). "Vaccine Approved for Child Infections". The New York Times. Archived from the original on 4 November 2015.

pharmaceutical-technology.com

Hazarika I (28 April 2023). "FDA clears Pfizer's Prevnar 20 vaccine for IPD prevention". Pharmaceutical Technology. Archived from the original on 3 May 2023. Retrieved 3 May 2023.

pneumoadip.com

"Vaccine Fund". PneumoADIP. Global Alliance for Vaccines and Immunization (GAVI); Johns Hopkins Bloomberg School of Public Health. Archived from the original on 8 February 2011.

sciencedaily.com

Jones CH, Zhang G, Nayerhoda R, Beitelshees M, Hill A, Rostami P, et al. (October 2017). "Comprehensive vaccine design for commensal disease progression". Science Advances. 3 (10): e1701797. Bibcode:2017SciA....3E1797J. doi:10.1126/sciadv.1701797. PMC 5647123. PMID 29057325.; Lay summary in: "The end of pneumonia? New vaccine offers hope: Vaccine under development provides the 'most comprehensive coverage' to date and alleviates antimicrobial concerns, new study finds". ScienceDaily. 20 October 2017. Archived from the original on 8 August 2022. Retrieved 12 July 2018.

semanticscholar.org

api.semanticscholar.org

Grabenstein JD, Klugman KP (October 2012). "A century of pneumococcal vaccination research in humans". Clinical Microbiology and Infection. 18 (Suppl 5): 15–24. doi:10.1111/j.1469-0691.2012.03943.x. PMID 22882735. S2CID 25558809.
Pletz MW, Maus U, Krug N, Welte T, Lode H (September 2008). "Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species". International Journal of Antimicrobial Agents. 32 (3): 199–206. doi:10.1016/j.ijantimicag.2008.01.021. PMID 18378430. S2CID 10514479.

thehindu.com

"Pneumonia vaccine to be part of immunisation drive". The Hindu. 14 May 2017. ISSN 0971-751X. Archived from the original on 18 August 2022. Retrieved 18 September 2017.

vaccineamc.org

"Saving Lives with New Vaccines: Advance Market Commitments". Advance Market Commitments for Vaccines (vaccineAMC). GAVI. November 2012. Archived from the original (PDF) on 6 March 2016.

vaxinfopro.be

"Pneumokokken - Nieuw advies Hoge Gezondheidsraad vaccinatie zuigelingen" [Pneumococcal: New advice from High Health Council concerning the vaccination of newborns]. vaxinfopro.be (in Dutch). 15 April 2019. Archived from the original on 1 February 2022. Retrieved 5 September 2020.

web.archive.org

"Vaccine Fund". PneumoADIP. Global Alliance for Vaccines and Immunization (GAVI); Johns Hopkins Bloomberg School of Public Health. Archived from the original on 8 February 2011.
"Pneumococcal Advance Market Commitment (AMC)". GAVI. Archived from the original on 7 June 2013.
Photography by Apostolia S (3 December 2019). "Gavi must stop giving millions in subsidies to Pfizer and GSK for pneumococcal vaccine". Doctors Without Borders. Archived from the original on 2 August 2022.
Photography by De Cock B (23 February 2011). "Pneumococcal Vaccine is Launched in Africa, But Are Donors Getting a Fair Deal from Companies?". Doctors Without Borders. Archived from the original on 14 September 2022.
Photograph by Ekholm K (2015). "Vaccination". Doctors Without Borders. Archived from the original on 27 June 2022.
"Pneumokokken - Nieuw advies Hoge Gezondheidsraad vaccinatie zuigelingen" [Pneumococcal: New advice from High Health Council concerning the vaccination of newborns]. vaxinfopro.be (in Dutch). 15 April 2019. Archived from the original on 1 February 2022. Retrieved 5 September 2020.
"Gratis pneumokokkenvaccin voor bewoners van woonzorgcentra" [Free pneumococcal vaccination for the residents of care homes]. laatjevaccineren.be (in Dutch). 9 November 2020. Archived from the original on 28 October 2021. Retrieved 5 September 2021.
"Pneumococcal vaccine: Canadian Immunization Guide". Government of Canada. 16 February 2020. Archived from the original on 1 September 2022.
"Pneumonia vaccine to be part of immunisation drive". The Hindu. 14 May 2017. ISSN 0971-751X. Archived from the original on 18 August 2022. Retrieved 18 September 2017.
van Twillert M (17 December 2020). "Gezondheidsraad: 'Doorgaan met pneumokokkenvaccinatie van ouderen'" [Health council: 'continue pneumococcal vaccination of elderly']. Medisch Contact (in Dutch). Archived from the original on 15 May 2021. Retrieved 4 September 2021.
"COVID-19 en vaccinatie tegen pneumokokken (2)" [COVID-19 and vaccination against pneumococcal (2)]. Health Council of the Netherlands (Gezondheidsraad) (in Dutch). 17 December 2020. Archived from the original on 19 September 2021. Retrieved 19 August 2021.
"Critical decline in pneumococcal disease and antibiotic resistance in South Africa". NICD. Archived from the original on 23 July 2015. Retrieved 20 July 2015.
"Children to be given new vaccine". BBC News. 8 February 2006. Archived from the original on 30 May 2006.
"Pneumococcal vaccine added to the childhood immunisation programme" (Press release). Department of Health and Social Care. 8 February 2006. Archived from the original on 23 October 2006.
"Changes to the immunisation programme in the UK". Meningitis Research Foundation. Archived from the original on 13 July 2007. Retrieved 6 May 2017.
"Synflorix, GlaxoSmithKline's pneumococcal vaccine receives European authorisation" (Press release). GlaxoSmithKline. 31 March 2009. Archived from the original on 4 August 2009.
"Pneumococcal Vaccination: Information for Health Care Providers". Centers for Disease Control and Prevention (CDC). 11 July 2016. Archived from the original on 23 July 2016. Retrieved 26 July 2016.
"Prevenar — Annex I: Summary of Product Characteristics" (PDF). European Medicines Agency. Archived from the original (PDF) on 17 December 2008.
Wilson D (24 February 2010). "Vaccine Approved for Child Infections". The New York Times. Archived from the original on 4 November 2015.
"Prevnar 13". U.S. Food and Drug Administration (FDA). 12 January 2012. STN: 125324. Archived from the original on 18 August 2011.
"Prevnar 20". Food and Drug Administration. 10 June 2021. Archived from the original on 6 September 2022. Retrieved 20 June 2021.
"FDA Greenlights Pfizer's Pneumococcal Vaccine in Infants and Children". BioSpace. Archived from the original on 3 May 2023. Retrieved 3 May 2023.
Hazarika I (28 April 2023). "FDA clears Pfizer's Prevnar 20 vaccine for IPD prevention". Pharmaceutical Technology. Archived from the original on 3 May 2023. Retrieved 3 May 2023.
"Supplemental Approval: 20-valent Pneumococcal Conjugate Vaccine (PREVNAR 20)". Food and Drug Administration. 27 April 2023. Archived from the original on 1 May 2023. Retrieved 12 May 2023.
Sniadack DH, Schwartz B, Lipman H, Bogaerts J, Butler JC, Dagan R, et al. (June 1995). "Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children--implications for vaccine strategies" (PDF). The Pediatric Infectious Disease Journal. 14 (6): 503–510. doi:10.1097/00006454-199506000-00007. PMID 7667055. Archived from the original on 28 August 2021.
"Saving Lives with New Vaccines: Advance Market Commitments". Advance Market Commitments for Vaccines (vaccineAMC). GAVI. November 2012. Archived from the original (PDF) on 6 March 2016.
"Acute Respiratory Infections (Update September 2009): Streptococcus pneumoniae". Initiative for Vaccine Research (IVR). World Health Organization (WHO). Archived from the original on 23 May 2012.
Jones CH, Zhang G, Nayerhoda R, Beitelshees M, Hill A, Rostami P, et al. (October 2017). "Comprehensive vaccine design for commensal disease progression". Science Advances. 3 (10): e1701797. Bibcode:2017SciA....3E1797J. doi:10.1126/sciadv.1701797. PMC 5647123. PMID 29057325.; Lay summary in: "The end of pneumonia? New vaccine offers hope: Vaccine under development provides the 'most comprehensive coverage' to date and alleviates antimicrobial concerns, new study finds". ScienceDaily. 20 October 2017. Archived from the original on 8 August 2022. Retrieved 12 July 2018.

who.int

"Acute Respiratory Infections (Update September 2009): Streptococcus pneumoniae". Initiative for Vaccine Research (IVR). World Health Organization (WHO). Archived from the original on 23 May 2012.

worldcat.org

"Pneumonia vaccine to be part of immunisation drive". The Hindu. 14 May 2017. ISSN 0971-751X. Archived from the original on 18 August 2022. Retrieved 18 September 2017.

zenodo.org

Sniadack DH, Schwartz B, Lipman H, Bogaerts J, Butler JC, Dagan R, et al. (June 1995). "Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children--implications for vaccine strategies" (PDF). The Pediatric Infectious Disease Journal. 14 (6): 503–510. doi:10.1097/00006454-199506000-00007. PMID 7667055. Archived from the original on 28 August 2021.